C12Q1/66

BIOLUMINESCENT SINGLE PHOTON BIOREACTOR AND PERFORMING ABSOLUTE QUANTIFICATION OF LIGHT-PRODUCING ACTIVITY BY ENZYMES
20220364144 · 2022-11-17 ·

A bioluminescent single photon bioreactor for performing absolute quantification of light-producing activity by enzymes includes: a bioreactor that produces a bio-electronic signal; an electronic sensor that receives the bio-electronic signal and produces an electrical transduction signal; and an analyzer that receives the electrical transduction signal and absolutely quantifies light-producing activity by enzymes from the electrical transduction signal, such that the absolute quantification is accomplished quantum mechanically by determination of a second order autocorrelation function.

BIOLUMINESCENT SINGLE PHOTON BIOREACTOR AND PERFORMING ABSOLUTE QUANTIFICATION OF LIGHT-PRODUCING ACTIVITY BY ENZYMES
20220364144 · 2022-11-17 ·

A bioluminescent single photon bioreactor for performing absolute quantification of light-producing activity by enzymes includes: a bioreactor that produces a bio-electronic signal; an electronic sensor that receives the bio-electronic signal and produces an electrical transduction signal; and an analyzer that receives the electrical transduction signal and absolutely quantifies light-producing activity by enzymes from the electrical transduction signal, such that the absolute quantification is accomplished quantum mechanically by determination of a second order autocorrelation function.

DEVICES AND METHODS FOR THE DETECTION OF BACTERIA

The present invention relates methods for rapidly detecting the presence of bacteria in biological solutions regardless of their origin in non-laboratory environments. The present invention further relates to methods for binding, capturing, and concentrating the bacteria in a given sample.

DEVICES AND METHODS FOR THE DETECTION OF BACTERIA

The present invention relates methods for rapidly detecting the presence of bacteria in biological solutions regardless of their origin in non-laboratory environments. The present invention further relates to methods for binding, capturing, and concentrating the bacteria in a given sample.

Activation of bioluminescene by structural complementation

Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide.

Activation of bioluminescene by structural complementation

Provided herein are compositions and methods for the assembly of a bioluminescent complex from two or more non-luminescent (e.g., substantially non-luminescent) peptide and/or polypeptide units. In particular, bioluminescent activity is conferred upon a non-luminescent polypeptide via structural complementation with another, complementary non-luminescent peptide.

Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems

The present invention relates to compositions comprising and methods of producing genetically engineered bacteriophages, bacteriophage-like particles and non-replicating transduction particles (NRTPs) that contain non-native tail fibers that display altered host specificity and/or reactivity. The present invention also relates to methods of using these bacteriophages and NRTPs for the development of novel diagnostics, therapeutics and/or research reagents for bacteria-related diseases.

Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems

The present invention relates to compositions comprising and methods of producing genetically engineered bacteriophages, bacteriophage-like particles and non-replicating transduction particles (NRTPs) that contain non-native tail fibers that display altered host specificity and/or reactivity. The present invention also relates to methods of using these bacteriophages and NRTPs for the development of novel diagnostics, therapeutics and/or research reagents for bacteria-related diseases.

SPLIT-ENZYME SYSTEM TO DETECT SPECIFIC DNA IN LIVING CELLS
20230031446 · 2023-02-02 ·

The present invention provides methods and compositions for detecting genomic sequences of interest in living cells. In particular, the present disclosure provides a split-enzyme system that works with guide RNAs and RNA-guided nucleases to produce detectable luminescent signals exclusively in the presence of targeted genomic sequences.

SPLIT-ENZYME SYSTEM TO DETECT SPECIFIC DNA IN LIVING CELLS
20230031446 · 2023-02-02 ·

The present invention provides methods and compositions for detecting genomic sequences of interest in living cells. In particular, the present disclosure provides a split-enzyme system that works with guide RNAs and RNA-guided nucleases to produce detectable luminescent signals exclusively in the presence of targeted genomic sequences.